16 related articles for article (PubMed ID: 3834163)
1. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
[No Abstract] [Full Text] [Related]
2. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
4. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
5. The clinical pharmacology of cytosine arabinoside.
Slevin ML; Piall EM; Aherne GW; Johnston A; Lister TA
Haematol Blood Transfus; 1983; 28():70-5. PubMed ID: 6862311
[No Abstract] [Full Text] [Related]
6. [High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)].
Yumura K; Kawa K; Ishihara S; Hara J; Doi S; Tomita K; Yabuuchi H
Rinsho Ketsueki; 1985 Dec; 26(12):1979-85. PubMed ID: 3834163
[No Abstract] [Full Text] [Related]
7. Studies on the cytotoxicity of cytosine arabinoside.
Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
